The Development of Pulmonary Edema after Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke Patient; Neurogenic or Non-Neurogenic?

The Development of Pulmonary Edema after Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke Patient; Neurogenic or Non-Neurogenic?

Recombinant tissue plasminogen activator (r-tPA) is the first-line drug for the treatment of acute ischemic stroke, despite it may lead to a variety of complications in some cases. In patients with extensive stroke, infarction of the brain can cause suppression of the respiratory center in the brain...

Full description

Bibliographic Details
Main Authors: Ahmad Sulaiman Alwahdy, Ika Yulieta Margaretha Sihombing, Fitria Tahta Alfina, Niken Syahdian, Putri Nurbaeti, Annisa Futihandayani, Allifka Ramadhanti
Format: Article
Language:English
Published: Karger Publishers 2022-08-01
Series:Case Reports in Neurology
Subjects:
stroke
ischemic
r-tpa
neurogenic pulmonary edema
acute pulmonary edema
Online Access:https://beta.karger.com/Article/FullText/526250

Internet

https://beta.karger.com/Article/FullText/526250

Similar Items